Oncology & Hematology

ReachCatalyst is a leading CNS CRO (clinical research organization), with a strong legacy in central nervous system diseases and disorders. Our experienced and therapeutically focused project teams play an important role in advancing clients’ compounds through the drug development process. We have deep knowledge of the nuances involved in successfully conducting CNS studies, from recruiting the right patients at the right time, to ensuring consistency in completing assessments, and ensuring all stakeholders involved are aligned.

​

ReachCatalyst has navigated challenging neurology clinical trial designs and complex patient populations, including programs with rare diseases. Our presence across the globe makes us well-versed with finding the right patients in a timely manner. Treatment settings for neurology and psychiatry patients can vary greatly across different parts of the world, and we have strategic and proven approaches to identify and attract these patients whether they are in institutional settings, nursing homes, or living at home with family members.

​

For many neurological studies, there is intense competition and demand for patients. Our strong site relationships and investigator alliances mean your program will get the attention it deserves. Additionally, our relationships with industry KOLs, central labs, and imaging centers help ensure standardization of assessments such as MRIs, CT scans, PET scans, and EEGs. From innovative and strategic planning, to our adaptable project teams, ReachCatalyst helps you operationalize and meet your project goals of high quality data and timely study execution.